Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Versha

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|March 11, 2020
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemiaSarit Assouline, Lilian Amrein, Raquel Aloyz, et al.
Leukemia & Lymphoma|January 18, 2024
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practiceVersha Banerji, Andrew Aw, Nicole Laferriere, et al.
Health Technology Assessment (Winchester, England)|August 5, 2015
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleedingT Justin Clark, Lee J Middleton, Natalie Am Cooper, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 1, 2025
National policies for screening and early detection of breast cancer around the globe: Practices, barriers, and solutionsVersha Pleasant, Charulata Bapaye, Femke Delporte, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 19, 2024
Patient and Public Involvement in Research Evaluating Integrated Care for People Experiencing Homelessness: Findings From the PHOENIx Community Pharmacy Pilot Randomised-Controlled TrialAndrew McPherson, Vibhu Paudyal, Richard Lowrie, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 9, 2025
Pharmacy Homeless Outreach Engagement Non-medical Independent Prescribing Rx (PHOENIx) Community Pharmacy-Based Pilot Randomized Controlled TrialRichard Lowrie, Vibhu Paudyal, Andrew McPherson, et al.
Leukemia Research|July 23, 2022
Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemiaMirela Anghelina, Michelle J Naughton, Qiuhong Zhao, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a DecadeJiayu Yang, Lin Yang, Bryan Tordon, et al.
Leukemia & Lymphoma|January 6, 2023
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registryRena Buckstein, Lisa Chodirker, Karen W L Yee, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|March 11, 2020
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemiaSarit Assouline, Lilian Amrein, Raquel Aloyz, et al.
Leukemia & Lymphoma|January 18, 2024
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practiceVersha Banerji, Andrew Aw, Nicole Laferriere, et al.
Health Technology Assessment (Winchester, England)|August 5, 2015
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleedingT Justin Clark, Lee J Middleton, Natalie Am Cooper, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 1, 2025
National policies for screening and early detection of breast cancer around the globe: Practices, barriers, and solutionsVersha Pleasant, Charulata Bapaye, Femke Delporte, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 19, 2024
Patient and Public Involvement in Research Evaluating Integrated Care for People Experiencing Homelessness: Findings From the PHOENIx Community Pharmacy Pilot Randomised-Controlled TrialAndrew McPherson, Vibhu Paudyal, Richard Lowrie, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 9, 2025
Pharmacy Homeless Outreach Engagement Non-medical Independent Prescribing Rx (PHOENIx) Community Pharmacy-Based Pilot Randomized Controlled TrialRichard Lowrie, Vibhu Paudyal, Andrew McPherson, et al.
Leukemia Research|July 23, 2022
Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemiaMirela Anghelina, Michelle J Naughton, Qiuhong Zhao, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a DecadeJiayu Yang, Lin Yang, Bryan Tordon, et al.
Leukemia & Lymphoma|January 6, 2023
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registryRena Buckstein, Lisa Chodirker, Karen W L Yee, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Pageof 19